DEA Removing Samidorphan From Controlled Substances List
The Drug Enforcement Administration is removing samidorphan from schedule II of the Controlled Substances Act, it said in a final rule released April 16. DEA said the drug has no abuse potential. The removal eliminates “regulatory controls and administrative, civil,…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
and criminal sanctions applicable to controlled substances, including those specific to schedule II controlled substances, on persons who handle (manufacture, distribute, reverse distribute, dispense, conduct research, import, export, or conduct chemical analysis) or propose to handle samidorphan,” the DEA said. The delisting is effective April 19.